Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.

D W Emery1, G Stamatoyannopoulos

  • 1University of Washington Department of Medicine, Seattle 98195, USA.

Annals of the New York Academy of Sciences
|June 18, 1999
PubMed
Summary

Virus vectors offer potential for gene therapy of beta-chain hemoglobinopathies. This review details novel vector systems and methods to improve gene transfer and expression in hematopoietic stem cells for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population structure of modern-day Italians reveals patterns of ancient and archaic ancestries in Southern Europe.

Science advances·2019
Same author

De novo mutations producing unstable hemoglobins or hemoglobins M : I. Establishment of a Depository and use of data to test for an association of de novo mutation with advanced parental age.

Human genetics·2016
Same author

Evidence for the in vivo safety of insulated foamy viral vectors.

Gene therapy·2016
Same author

The cHS4 chromatin insulator reduces gammaretroviral vector silencing by epigenetic modifications of integrated provirus.

Gene therapy·2007
Same author

Prospects for developing a molecular cure for thalassemia.

Hematology (Amsterdam, Netherlands)·2005
Same author

Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.

Gene therapy·2005

Area of Science:

  • * Hematology
  • * Gene Therapy
  • * Molecular Biology

Background:

  • * Beta-chain hemoglobinopathies are genetic blood disorders requiring effective treatments.
  • * Current gene therapy approaches using virus vectors face challenges like low gene transfer and expression.
  • * Hematopoietic stem cell (HSC) transduction is crucial for durable gene therapy.

Purpose of the Study:

  • * To review current vector systems for HSC gene therapy.
  • * To discuss strategies for enhancing gene transfer and expression levels.
  • * To explore methods for selecting successfully transduced HSCs in vivo.

Main Methods:

  • * Review of existing literature on viral vector systems for HSC transduction.
  • * Analysis of novel vector development and selection techniques.

Related Experiment Videos

  • * Examination of methods to optimize therapeutic globin gene expression.

    • Main Results:

    • * Development of novel vector systems shows promise for improved HSC transduction.
    • * Strategies like transcription cassette manipulation and enhancer use increase gene expression.
    • * Chromatin insulators enhance the frequency of gene expression post-HSC transduction.

    Conclusions:

    • * Advanced vector systems and selection methods are improving HSC gene therapy for hemoglobinopathies.
    • * Optimizing gene expression through molecular techniques is key to therapeutic success.
    • * Continued research in vector design and gene regulation is vital for clinical application.